Search Results

A phase 3 adaptive dose selection trial of NCX 470, a nitric oxide-donating bimatoprost for open-angle glaucoma or ocular hypertension: The MONT BLANC study.

• Authors : Mansberger SL; Chenoweth Chair of Ophthalmology and Director of Glaucoma Services at Legacy Devers Eye Institute, Portland, OR, United States of America. Electronic address: .; Fechtner R

Subjects: Glaucoma, Open-Angle*/Glaucoma, Open-Angle*/Glaucoma, Open-Angle*/drug therapy ; Ocular Hypertension*/Ocular Hypertension*/Ocular Hypertension*/drug therapy ; Intraocular Pressure*/Intraocular Pressure*/Intraocular Pressure*/drug effects

• Source: Contemporary clinical trials [Contemp Clin Trials] 2024 Dec; Vol. 147, pp. 107730. Date of Electronic Publication: 2024 Oct 28.Publisher: Elsevier Country of Publication: United States NLM ID: 101242342 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Cystoid macular edema occurring after intracameral bimatoprost implantation.

• Authors : Bettach E; Department of Ophthalmology, Shaare Zedek Medical Center, Jerusalem, Israel.; Wiener R

Subjects: Macular Edema*/Macular Edema*/Macular Edema*/diagnosis ; Macular Edema*/Macular Edema*/Macular Edema*/drug therapy ; Bimatoprost*/Bimatoprost*/Bimatoprost*/adverse effects

• Source: European journal of ophthalmology [Eur J Ophthalmol] 2024 Jul; Vol. 34 (4), pp. NP20-NP24. Date of Electronic Publication: 2024 Apr 15.Publisher: SAGE Publishing Country of Publication: United States NLM ID: 9110772 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

A Randomized, Controlled Comparison of NCX 470, a Nitric Oxide-Donating Bimatoprost, and Latanoprost in Subjects with Open-Angle Glaucoma or Ocular Hypertension: The MONT BLANC Study.

• Authors : Fechtner R; Department of Ophthalmology and Visual Sciences, SUNY Upstate Medical University (R.F.), Syracuse, New York, USA. Electronic address: .; Mansberger S

Subjects: Glaucoma, Open-Angle*/Glaucoma, Open-Angle*/Glaucoma, Open-Angle*/drug therapy ; Glaucoma, Open-Angle*/Glaucoma, Open-Angle*/Glaucoma, Open-Angle*/physiopathology ; Latanoprost*/Latanoprost*/Latanoprost*/therapeutic use

• Source: American journal of ophthalmology [Am J Ophthalmol] 2024 Aug; Vol. 264, pp. 66-74. Date of Electronic Publication: 2024 Mar 16.Publisher: Elsevier Science Country of Publication: United States NLM ID: 0370500 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

The role of fractional laser-assisted drug delivery in enhancing the efficacy of topical bimatoprost solution in the treatment of alopecia areata: An intra-patient comparative randomized clinical trial.

• Authors : Meymandi SS; Pathology and Stem Cell Research Center, Afzalipour Hospital, Kerman University of Medical Sciences, Kerman, Iran.; Safari A

Subjects: Alopecia Areata*/Alopecia Areata*/Alopecia Areata*/drug therapy ; Alopecia Areata*/Alopecia Areata*/Alopecia Areata*/therapy ; Bimatoprost*/Bimatoprost*/Bimatoprost*/administration & dosage

• Source: Journal of cosmetic dermatology [J Cosmet Dermatol] 2024 May; Vol. 23 (5), pp. 1663-1668. Date of Electronic Publication: 2024 Feb 07.Publisher: Blackwell Science Country of Publication: England NLM ID: 101130964 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

The Effect of Bimatoprost Implant on Glaucoma Patients: An Observational Study.

• Authors : Choi EY; Department of Ophthalmology, Duke University, Durham, NC.; Johnson NA

Subjects: Bimatoprost*/Bimatoprost*/Bimatoprost*/administration & dosage ; Intraocular Pressure*/Intraocular Pressure*/Intraocular Pressure*/physiology ; Intraocular Pressure*/Intraocular Pressure*/Intraocular Pressure*/drug effects

• Source: Journal of glaucoma [J Glaucoma] 2024 Jun 01; Vol. 33 (6), pp. 431-436. Date of Electronic Publication: 2024 Mar 04.Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 9300903 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Comparative study between efficacy of Excimer light with topical Tacrolimus 0.1% versus excimer light with topical Bimatoprost 0.01% in treatment of facial Vitiligo.

• Authors : Zaky MS; Department of Dermatology, Venereology and Andrology, Damietta Faculty of Medicine, Al-Azhar University, Damietta, Egypt.; Atallah RB

Subjects: Vitiligo*/Vitiligo*/Vitiligo*/drug therapy ; Vitiligo*/Vitiligo*/Vitiligo*/therapy ; Vitiligo*/Vitiligo*/Vitiligo*/diagnosis

• Source: Archives of dermatological research [Arch Dermatol Res] 2024 Jun 08; Vol. 316 (7), pp. 350. Date of Electronic Publication: 2024 Jun 08.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8000462 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-069X

Record details

Preservative-Free Bimatoprost 0.01% Ophthalmic Gel for Glaucoma Therapy: A Phase III Randomized Controlled Trial.

• Authors : Muñoz-Negrete FJ; Department of Ophthalmology, Hospital Universitario Ramón y Cajal.; Faculty of Medicine, University of Alcalá, IRYCIS, Madrid, Spain (Facultad de Medicina, Universidad de Alcalá, IRYCIS, Madrid, Spain).

Subjects: Bimatoprost*/Bimatoprost*/Bimatoprost*/administration & dosage ; Intraocular Pressure*/Intraocular Pressure*/Intraocular Pressure*/drug effects ; Intraocular Pressure*/Intraocular Pressure*/Intraocular Pressure*/physiology

• Source: Journal of glaucoma [J Glaucoma] 2024 Jun 01; Vol. 33 (6), pp. 422-430. Date of Electronic Publication: 2024 Mar 04.Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 9300903 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Fractional non-ablative assisted bimatoprost delivery: A synergistic approach for treating post-inflammatory hypopigmentation following cosmetic procedures in skin of color patients.

• Authors : Jablon K; Renaissance School of Medicine at Stony Brook University, Stony Brook, New York, USA.; Theisen E

Subjects: Bimatoprost*/Bimatoprost*/Bimatoprost*/administration & dosage ; Hypopigmentation*/Hypopigmentation*/Hypopigmentation*/etiology ; Skin Pigmentation*

• Source: Lasers in surgery and medicine [Lasers Surg Med] 2024 Jan; Vol. 56 (1), pp. 11-13. Date of Electronic Publication: 2023 Nov 29.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8007168 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Eyelash serums: A comprehensive review.

• Authors : Baiyasi M; Wayne State University School of Medicine, Detroit, Michigan, USA.; St Claire K

Subjects: Eyelashes*/Eyelashes*/Eyelashes*/drug effects ; Bimatoprost*/Bimatoprost*/Bimatoprost*/administration & dosage ; Bimatoprost*/Bimatoprost*/Bimatoprost*/adverse effects

• Source: Journal of cosmetic dermatology [J Cosmet Dermatol] 2024 Jul; Vol. 23 (7), pp. 2328-2344. Date of Electronic Publication: 2024 Mar 12.Publisher: Blackwell Science Country of Publication: England NLM ID: 101130964 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Combined microneedling with topical vitamin D3 or bimatoprost versus microneedling alone in the treatment of alopecia areata: A comparative randomized trial.

• Authors : Ali MS; Faculty of Medicine (Girls), Al- Azhar University, Cairo, Egypt.; Hafiz HSA

Subjects: Alopecia Areata*/Alopecia Areata*/Alopecia Areata*/drug therapy ; Alopecia Areata*/Alopecia Areata*/Alopecia Areata*/therapy ; Bimatoprost*/Bimatoprost*/Bimatoprost*/administration & dosage

• Source: Journal of cosmetic dermatology [J Cosmet Dermatol] 2023 Apr; Vol. 22 (4), pp. 1286-1296. Date of Electronic Publication: 2023 Feb 10.Publisher: Blackwell Science Country of Publication: England NLM ID: 101130964 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Preparation of topical bimatoprost with enhanced skin infiltration and in vivo hair regrowth efficacy in androgenic alopecia.

• Authors : Subedi L; Department of Biomedicine, Health & Life Convergence Sciences, BK21 Four, Biomedical and Healthcare Research Institute, Mokpo National University, Jeonnam, Republic of Korea.; Pandey P

Subjects: Drug Delivery Systems*; Alopecia/Alopecia/Alopecia/*pathology ; Bimatoprost/Bimatoprost/Bimatoprost/*pharmacology

• Source: Drug delivery [Drug Deliv] 2022 Dec; Vol. 29 (1), pp. 328-341.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9417471 Publication Model: Print Cited Medium: Internet ISSN: 1521-0464

Record details

Ocular Surface Disease in Glaucoma Patients Randomized to Benzalkonium Chloride-Containing Latanoprost and Preservative-Free Bimatoprost.

• Authors : Wu JH; Shiley Eye Institute and Viterbi Family Department of Ophthalmology, University of California, San Diego, California, USA.; Wang TH

Subjects: Benzalkonium Compounds/Benzalkonium Compounds/Benzalkonium Compounds/*therapeutic use ; Bimatoprost/Bimatoprost/Bimatoprost/*therapeutic use ; Glaucoma/Glaucoma/Glaucoma/*drug therapy

• Source: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics [J Ocul Pharmacol Ther] 2021 Dec; Vol. 37 (10), pp. Publisher: Association For Ocular Pharmacology And Therapeutics Country of Publication: United States NLM ID: 9511091 Publication Model: Print-Electronic

Record details

Phase 3, Randomized, 20-Month Study of the Efficacy and Safety of Bimatoprost Implant in Patients with Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 2).

• Authors : Bacharach J; Tatham A ...

Subjects: Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*therapeutic use ; Bimatoprost/Bimatoprost/Bimatoprost/*therapeutic use ; Drug Implants/Drug Implants/Drug Implants/*therapeutic use

• Source: Drugs [Drugs] 2021 Nov; Vol. 81 (17), pp. 2017-2033. Date of Electronic Publication: 2021 Nov 01.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 7600076 Publication Model: Print-Electronic Cited Medium: Internet

Record details

24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients.

• Authors : Craven ER; Walters T ...

Subjects: Absorbable Implants*; Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*administration & dosage ; Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*therapeutic use

• Source: Drugs [Drugs] 2020 Feb; Vol. 80 (2), pp. 167-179.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 7600076 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Comparison of the efficacy and safety of using 0.01% versus 0.03% bimatoprost for the treatment of eyebrow hypotrichosis: A randomized, double-blind, split-face, comparative study.

• Authors : Suchonwanit P; Division of Dermatology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.; Harnchoowong S

Subjects: Bimatoprost/Bimatoprost/Bimatoprost/*administration & dosage ; Eyebrows/Eyebrows/Eyebrows/*drug effects ; Hypotrichosis/Hypotrichosis/Hypotrichosis/*drug therapy

• Source: Journal of cosmetic dermatology [J Cosmet Dermatol] 2020 Mar; Vol. 19 (3), pp. 714-719. Date of Electronic Publication: 2019 Jul 17.Publisher: Blackwell Science Country of Publication: England NLM ID: 101130964 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Bimatoprost Imprinted Silicone Contact Lens to Treat Glaucoma.

• Authors : Yan F; Department of Ophthalmology, Ningcheng Central Hospital, Chifeng, 024200, Neimenggu, China.; Liu Y

Subjects: Contact Lenses*; Bimatoprost/Bimatoprost/Bimatoprost/*administration & dosage ; Glaucoma/Glaucoma/Glaucoma/*drug therapy

• Source: AAPS PharmSciTech [AAPS PharmSciTech] 2020 Jan 13; Vol. 21 (2), pp. 63. Date of Electronic Publication: 2020 Jan 13.Publisher: Springer Country of Publication: United States NLM ID: 100960111 Publication Model: Electronic Cited Medium: Internet ISSN: 1530-9932

Record details

Durysta - a bimatoprost implant for glaucoma.

Subjects: Prostheses and Implants*; Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*therapeutic use ; Bimatoprost/Bimatoprost/Bimatoprost/*therapeutic use

• Source: The Medical letter on drugs and therapeutics [Med Lett Drugs Ther] 2020 Jul 27; Vol. 62 (1603), pp. 116-117.Publisher: The Medical Letter Country of Publication: United States NLM ID: 2985240R Publication Model: Print Cited Medium: Internet ISSN:

Record details

Efficacy of bimatoprost for the treatment of primary open-angle glaucoma: A protocol of systematic review and meta-analysis.

• Authors : Liu HW; Department of Ophthalmology, First Affiliated Hospital of Jiamusi University, Jiamusi, China.; Lu YT

Subjects: Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*therapeutic use ; Bimatoprost/Bimatoprost/Bimatoprost/*therapeutic use ; Glaucoma, Open-Angle/Glaucoma, Open-Angle/Glaucoma, Open-Angle/*drug therapy

• Source: Medicine [Medicine (Baltimore)] 2020 Jun 05; Vol. 99 (23), pp. e20356.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN:

Record details

Bimatoprost Implant: First Approval.

• Authors : Shirley M; Springer Nature, Private Bag 65,901, Mairangi Bay, Auckland, 0754, New Zealand. .

Subjects: Drug Approval* ; Prostheses and Implants*; Bimatoprost/Bimatoprost/Bimatoprost/*pharmacology

• Source: Drugs & aging [Drugs Aging] 2020 Jun; Vol. 37 (6), pp. 457-462.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9102074 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Bimatoprost SR for Glaucoma Therapy Implanted at the Slit-Lamp in a Real-World Setting

• Authors : Ali, Arsalan Akbar; Elescano, Denisse Aviles; Grover, Davinder S.

• Source: Clinical Ophthalmology. May 31, 2024, Vol. 18, p1371, 7 p.

Record details

Dose-Response of Intracameral Bimatoprost Sustained-Release Implant and Topical Bimatoprost in Lowering Intraocular Pressure.

• Authors : Lee SS; Allergan plc, Irvine, California.; Dibas M

Subjects: Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*pharmacology ; Bimatoprost/Bimatoprost/Bimatoprost/*pharmacology ; Intraocular Pressure/Intraocular Pressure/Intraocular Pressure/*drug effects

• Source: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics [J Ocul Pharmacol Ther] 2019 Apr; Vol. 35 (3), pp. Publisher: Association For Ocular Pharmacology And Therapeutics Country of Publication: United States NLM ID: 9511091 Publication Model: Print-Electronic

Record details

Intracameral Sustained-Release Bimatoprost Implant Delivers Bimatoprost to Target Tissues with Reduced Drug Exposure to Off-Target Tissues.

• Authors : Seal JR; 1 Allergan plc, Irvine, California.; Robinson MR

Subjects: Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*therapeutic use ; Bimatoprost/Bimatoprost/Bimatoprost/*therapeutic use ; Intraocular Pressure/Intraocular Pressure/Intraocular Pressure/*drug effects

• Source: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics [J Ocul Pharmacol Ther] 2019 Jan/Feb; Vol. 35 (1), pp. Publisher: Association For Ocular Pharmacology And Therapeutics Country of Publication: United States NLM ID: 9511091 Publication Model: Print-Electronic

Record details

Bimatoprost loaded nanovesicular long-acting sub-conjunctival in-situ gelling implant: In vitro and in vivo evaluation.

• Authors : Yadav M; University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India.; Guzman-Aranguez A

Subjects: Bimatoprost*/Bimatoprost*/Bimatoprost*/chemistry ; Bimatoprost*/Bimatoprost*/Bimatoprost*/pharmacokinetics ; Bimatoprost*/Bimatoprost*/Bimatoprost*/pharmacology

• Source: Materials science & engineering. C, Materials for biological applications [Mater Sci Eng C Mater Biol Appl] 2019 Oct; Vol. 103, pp. 109730. Date of Electronic Publication: 2019 MayPublisher: Elsevier Country of Publication: Netherlands NLM ID: 101484109 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Efficacy and Safety of Bimatoprost 0.01% for the Treatment of Eyebrow Hypotrichosis: A Randomized, Double-Blind, Vehicle-Controlled Study.

• Authors : Suchonwanit P; All authors are affiliated with the Division of Dermatology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.; Chanasumon N

Subjects: Patient Satisfaction*; Bimatoprost/Bimatoprost/Bimatoprost/*administration & dosage ; Eyebrows/Eyebrows/Eyebrows/*drug effects

• Source: Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] [Dermatol Surg] 2019 Dec; Vol. 45 (12), pp. 1549-1556.Publisher: Wolters Kluwer Health Country of Publication: United States NLM ID: 9504371 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Real-World Analysis of the Efficacy of Bimatoprost Sustained-Release Glaucoma Implant Where American Indians Comprise the Largest Minority Population

• Authors : Sarkisian, Steven R., Jr.; Mitchell, Evann C.

• Source: Clinical Ophthalmology. March 31, 2024, Vol. 18, p917, 11 p.

Record details

Bimatoprost-induced iris hyperpigmentation: beauty in the darkened eye of the beholder.

• Authors : Lipp MB; Lake Erie Consortium for Osteopathic Medical Training - Larkin Community Hospital Palm Springs Campus, Hialeah, Florida, USA.; Athalye L

Subjects: Bimatoprost/Bimatoprost/Bimatoprost/*adverse effects ; Hyperpigmentation/Hyperpigmentation/Hyperpigmentation/*chemically induced ; Iris/Iris/Iris/*drug effects

• Source: Cutis [Cutis] 2019 Aug; Vol. 104 (2), pp. E7-E9.Publisher: Frontline Medical Communications Country of Publication: United States NLM ID: 0006440 Publication Model: Print Cited Medium: Internet

Record details

Real-World Study of the Effectiveness and Safety of Intracameral Bimatoprost Implant in a Clinical Setting in the United States

• Authors : Teymoorian, Savak; Craven, E. Randy; Nguyen, Lannhi

• Source: Clinical Ophthalmology. January 31, 2024, Vol. 18, p187, 13 p.

Record details

Changes in ocular signs and symptoms in patients switching from bimatoprost-timolol to tafluprost-timolol eye drops: an open-label phase IV study.

• Authors : Bourne RRA; Cambridge University Hospitals, Cambridge, UK.; Vision and Eye Research Unit, Anglia Ruskin University, Cambridge, UK.

Subjects: Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*administration & dosage ; Bimatoprost/Bimatoprost/Bimatoprost/*administration & dosage ; Glaucoma, Open-Angle/Glaucoma, Open-Angle/Glaucoma, Open-Angle/*drug therapy

• Source: BMJ open [BMJ Open] 2019 Apr 02; Vol. 9 (4), pp. e024129. Date of Electronic Publication: 2019 Apr 02.Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Decreased orbital fat and enophthalmos due to bimatoprost: Quantitative analysis using magnetic resonance imaging.

• Authors : Higashiyama T; Department of Ophthalmology, Shiga University of Medical Science, Otsu, Shiga, Japan.; Minamikawa T

Subjects: Enophthalmos*/Enophthalmos*/Enophthalmos*/chemically induced ; Enophthalmos*/Enophthalmos*/Enophthalmos*/diagnostic imaging ; Glaucoma*/Glaucoma*/Glaucoma*/diagnostic imaging

• Source: PloS one [PLoS One] 2019 Mar 27; Vol. 14 (3), pp. e0214065. Date of Electronic Publication: 2019 Mar 27 (Print Publication: 2019).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

Bimatoprost for the treatment of female androgenetic alopecia—A case report.

• Authors : Gressenberger, Paul¹ (AUTHOR) ; Kopera, Daisy¹ (AUTHOR)

Subjects: *BIMATOPROST; *BALDNESS; *PHOTOBIOMODULATION therapy

• Source: Dermatologic Therapy. Sep2022, Vol. 35 Issue 9, p1-2. 2p.

Record details

Phase 3, Randomized, 20-Month Study of Bimatoprost Implant in Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 1).

• Authors : Medeiros FA; Walters TR ...

Subjects: Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*administration & dosage ; Bimatoprost/Bimatoprost/Bimatoprost/*administration & dosage ; Glaucoma, Open-Angle/Glaucoma, Open-Angle/Glaucoma, Open-Angle/*drug therapy

• Source: Ophthalmology [Ophthalmology] 2020 Dec; Vol. 127 (12), pp. 1627-1641. Date of Electronic Publication: 2020 Jun 13.Publisher: Elsevier Country of Publication: United States NLM ID: 7802443 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Effect of prostaglandin analogs: Latanoprost, bimatoprost, and unoprostone on matrix metalloproteinases and their inhibitors in human trabecular meshwork endothelial cells.

• Authors : Heo JY; Department of Ophthalmology, University Hospitals Cleveland Medical Center, 11100 Euclid Avenue, Cleveland, OH, 44106, USA.; Ooi YH

Subjects: Bimatoprost/Bimatoprost/Bimatoprost/*pharmacology ; Glaucoma, Open-Angle/Glaucoma, Open-Angle/Glaucoma, Open-Angle/*drug therapy ; Latanoprost/Latanoprost/Latanoprost/*pharmacology

• Source: Experimental eye research [Exp Eye Res] 2020 May; Vol. 194, pp. 108019. Date of Electronic Publication: 2020 Mar 25.Publisher: Academic Press Country of Publication: England NLM ID: 0370707 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

From Eye Care to Hair Growth: Bimatoprost.

• Authors : Zeppieri, Marco; Gagliano, Caterina; Spadea, Leopoldo

Subjects: EYELASHES; HAIR growth; BIMATOPROST

• Source: Pharmaceuticals (14248247); May2024, Vol. 17 Issue 5, p561, 35p

Record details

Open-label pilot study to evaluate the effectiveness of topical bimatoprost on rhododendrol-induced refractory leukoderma.

• Authors : Fukaya S; Department of Dermatology, Teikyo University School of Medicine, Tokyo, Japan.; Kamata M

Subjects: Bimatoprost/Bimatoprost/Bimatoprost/*therapeutic use ; Butanols/Butanols/Butanols/*adverse effects ; Hypopigmentation/Hypopigmentation/Hypopigmentation/*drug therapy

• Source: The Journal of dermatology [J Dermatol] 2018 Nov; Vol. 45 (11), pp. 1283-1288. Date of Electronic Publication: 2018 Aug 29.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7600545 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Bimatoprost sustained-release intracameral implant reduces episcleral venous pressure in dogs.

• Authors : Lee SS; Allergan plc, Irvine, CA, USA.; Burke J

Subjects: Bimatoprost/Bimatoprost/Bimatoprost/*therapeutic use ; Dog Diseases/Dog Diseases/Dog Diseases/*drug therapy ; Sclera/Sclera/Sclera/*blood supply

• Source: Veterinary ophthalmology [Vet Ophthalmol] 2018 Jul; Vol. 21 (4), pp. 376-381. Date of Electronic Publication: 2018 Feb 19.Publisher: Blackwell Science Country of Publication: England NLM ID: 100887377 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Bimatoprost ophthalmic solution in facial vitiligo.

• Authors : Jha AK; Department of Skin & V.D, Patna Medical College & Hospital, Patna, India.; Prasad S

Subjects: Bimatoprost/Bimatoprost/Bimatoprost/*therapeutic use ; Facial Dermatoses/Facial Dermatoses/Facial Dermatoses/*drug therapy ; Ophthalmic Solutions/Ophthalmic Solutions/Ophthalmic Solutions/*therapeutic use

• Source: Journal of cosmetic dermatology [J Cosmet Dermatol] 2018 Jun; Vol. 17 (3), pp. 437-440. Date of Electronic Publication: 2017 Oct 15.Publisher: Blackwell Science Country of Publication: England NLM ID: 101130964 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Investigators from Legacy Devers Eye Institute Report New Data on Open-Angle Glaucoma (A Phase 3 Adaptive Dose Selection Trial of Ncx 470, a Nitric Oxide-donating Bimatoprost for Open-angle Glaucoma or Ocular Hypertension: the Mont Blanc Study)

• Source: Obesity, Fitness & Wellness Week. December 14, 2024, 1015

Record details

The Effect of Prostaglandin Analogue Bimatoprost on Thyroid-Associated Orbitopathy.

• Authors : Choi CJ; Dr. Nasser Al-Rashid Orbital Vision Research Center, Bascom Palmer Eye Institute, Department of Ophthalmology, McKnight Vision Research Center, University of Miami School of Medicine, Miami, Florida, United States.; Tao W

Subjects: Adipose Tissue/Adipose Tissue/Adipose Tissue/*drug effects ; Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*pharmacology ; Bimatoprost/Bimatoprost/Bimatoprost/*pharmacology

• Source: Investigative ophthalmology & visual science [Invest Ophthalmol Vis Sci] 2018 Dec 03; Vol. 59 (15), pp. 5912-5923.Publisher: Association For Research In Vision And Ophthalmology (Arvo) Country of Publication: United States NLM ID: 7703701 Publication Model: Print Cited

Record details

Tear biomarkers in latanoprost and bimatoprost treated eyes.

• Authors : Reddy S; Hyderabad Eye Research Foundation (HERF), L.V. Prasad Eye Institute, Bhubaneswar, India.; Sahay P

Subjects: Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*therapeutic use ; Bimatoprost/Bimatoprost/Bimatoprost/*therapeutic use ; Latanoprost/Latanoprost/Latanoprost/*therapeutic use

• Source: PloS one [PLoS One] 2018 Aug 06; Vol. 13 (8), pp. e0201740. Date of Electronic Publication: 2018 Aug 06 (Print Publication: 2018).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

A prospective right-left comparative study to evaluate the efficacy and tolerability of combination of NB-UVB and topical bimatoprost 0.03% eye drops versus NB-UVB given alone in patients of vitiligo vulgaris.

• Authors : Sharma S; Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.; Parsad D

Subjects: Ultraviolet Therapy*; Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*therapeutic use ; Bimatoprost/Bimatoprost/Bimatoprost/*therapeutic use

• Source: Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2018 Aug; Vol. 32 (8), pp. e330-e331. Date of Electronic Publication: 2018 MarPublisher: Wiley-Blackwell Country of Publication: England NLM ID: 9216037 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Bimatoprost Can Increase Growth and Density of Eyebrow Hair: A Prospective Study on a Group of Young Women.

• Authors : Załęcki, Piotr; Skakowska, Justyna; Nowicka, Danuta

Subjects: EYEBROWS; YOUNG women; BIMATOPROST

• Source: Applied Sciences (2076-3417); Jul2024, Vol. 14 Issue 13, p5848, 12p

Record details

Phase 3, Randomized Study Comparing Intracameral Bimatoprost Implant 15 [micro]g and Selective Laser Trabeculectomy in Patients with Open-Angle Glaucoma or Ocular Hypertension

• Authors : Christie, William C.; Basha, Mahdi M.; Ho, Quoc

• Source: Clinical Ophthalmology. October 31, 2023, Vol. 17, p3023, 14 p.

Record details

Bimatoprost implant reduces IOP for 2 years or more.

• Authors : Charters, Lynda

Subjects: *BIMATOPROST; *DRUG approval; *GLAUCOMAUNITED States. Food & Drug Administration

• Source: Ophthalmology Times. Jan2022, Vol. 47 Issue 1, p14-15. 2p.

Record details

Long-term Use of Topical Bimatoprost on Rhododendrol-induced Refractory Leukoderma: A Case Report.

• Authors : Fukaya S; Department of Dermatology, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-k, Tokyo 113-8655, Japan.; Kamata M

Subjects: Bimatoprost/Bimatoprost/Bimatoprost/*administration & dosage ; Butanols/Butanols/Butanols/*adverse effects ; Cosmetics/Cosmetics/Cosmetics/*adverse effects

• Source: Acta dermato-venereologica [Acta Derm Venereol] 2019 Nov 01; Vol. 99 (12), pp. 1178-1179.Publisher: Society for the Publication of Acta Dermato-Venereologica Country of Publication: Sweden NLM ID: 0370310 Publication Model: Print Cited Medium:

Record details

Prospective randomized clinical trial on the effects of latanoprost, travoprost and bimatoprost on latanoprost non-responders.

• Authors : Blondeau P; Department of Ophthalmology, University of Sherbrooke, CHUS, Sherbrooke, Canada. Electronic address: .; Hamid M

Subjects: Bimatoprost/Bimatoprost/Bimatoprost/*therapeutic use ; Exfoliation Syndrome/Exfoliation Syndrome/Exfoliation Syndrome/*drug therapy ; Glaucoma, Open-Angle/Glaucoma, Open-Angle/Glaucoma, Open-Angle/*drug therapy

• Source: Journal francais d'ophtalmologie [J Fr Ophtalmol] 2019 Oct; Vol. 42 (8), pp. 894-899. Date of Electronic Publication: 2019 Jun 01.Publisher: Masson Country of Publication: France NLM ID: 7804128 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1773-0597

Record details

Development and validation of the stability indicating RP-UHPLC method for the determination of the chemical purity and assay of bimatoprost.

• Authors : Zezula M; Pharmaceutical Research Institute, Warsaw 01-793, Poland. Electronic address: .; Ruszczak M

Subjects: Drug Contamination* ; Drug Stability*; Bimatoprost/Bimatoprost/Bimatoprost/*analysis

• Source: Journal of pharmaceutical and biomedical analysis [J Pharm Biomed Anal] 2019 Sep 10; Vol. 174, pp. 348-359. Date of Electronic Publication: 2019 Jun 10.Publisher: Elsevier Science Country of Publication: England NLM ID: 8309336 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Effects of LATISSE (bimatoprost 0.03 per cent topical solution) on the ocular surface.

• Authors : Bitton E; École d'optométrie, Université de Montréal, Montreal, Quebec, Canada.; Courey C

Subjects: Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*administration & dosage ; Bimatoprost/Bimatoprost/Bimatoprost/*administration & dosage ; Eyelashes/Eyelashes/Eyelashes/*drug effects

• Source: Clinical & experimental optometry [Clin Exp Optom] 2017 Nov; Vol. 100 (6), pp. 583-589. Date of Electronic Publication: 2017 Jan 25.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 8703442 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Re-pigmentation of Hypopigmentation: Fractional Lasers vs Laser-Assisted Delivery of Bimatoprost vs Epidermal Melanocyte Harvesting System

• Authors : Waibel JS; Rudnick A; Arheart KL

Subjects: Melanocytes*; Bimatoprost/Bimatoprost/Bimatoprost/*administration & dosage ; Dermatologic Agents/Dermatologic Agents/Dermatologic Agents/*administration & dosage

• Source: Journal of drugs in dermatology : JDD [J Drugs Dermatol] 2019 Nov 01; Vol. 18 (11), pp. 1090-1096.Publisher: Physicians Continuing Education Corporation Country of Publication: United States NLM ID: 101160020 Publication Model: Print Cited Medium:

Record details

Retrospective Evaluation of Topical Bimatoprost and Iris Pigmentation Change.

• Authors : Zaleski-Larsen LA; West Dermatology, San Diego, California.; Ruth NH

Subjects: Bimatoprost/Bimatoprost/Bimatoprost/*pharmacology ; Eyelashes/Eyelashes/Eyelashes/*drug effects ; Hypotrichosis/Hypotrichosis/Hypotrichosis/*drug therapy

• Source: Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] [Dermatol Surg] 2017 Dec; Vol. 43 (12), pp. 1431-1433.Publisher: Wolters Kluwer Health Country of Publication: United States NLM ID: 9504371 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Long-term Safety and Efficacy of a Sustained-Release Bimatoprost Ocular Ring.

• Authors : Brandt JD; DuBiner HB ...

Subjects: Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*administration & dosage ; Bimatoprost/Bimatoprost/Bimatoprost/*administration & dosage ; Drug Implants/Drug Implants/Drug Implants/*therapeutic use

• Source: Ophthalmology [Ophthalmology] 2017 Oct; Vol. 124 (10), pp. 1565-1566. Date of Electronic Publication: 2017 May 17.Publisher: Elsevier Country of Publication: United States NLM ID: 7802443 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details